Caixin
Oct 27, 2021 08:00 AM

Changzhou Qianhong Bio-Pharma Co.,Ltd.’s Net Profit Rose 34.5% in First Three Quarters of 2021

Changzhou Qianhong Bio-Pharma Co.,Ltd. (常州千红生化制药股份有限公司) (002550.SZ) reported a net profit of 184 million yuan in the first three quarters of 2021, up 34.5% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, up 17.7% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 261.5 million yuan in total liabilities, with a liability-to-asset ratio of 11%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin China Biz Roundup: Rape Allegations at Acting School Spark Uproar
00:00
00:00/00:00